Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective effects of taurine against MTX, gentamicin and carbamazepine toxicity
IRCT138812123482N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of taurine in acute lymphoblastic leukemia (ALL), Infectious disease and seizure disorder (3 arms), sponsored by Tabriz University of Medical Sciences. Started Sep 2010; status: completed.
02
Drugs
taurine
03
Conditions
acute lymphoblastic leukemia (ALL)Infectious diseaseseizure disorder
Beyond the preview
Go deeper on IRCT138812123482N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138812123482N1.